Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a Exploratory Study of TAR-0520 Gel in Prevention of Hand and Foot Syndrome

NCT07457671 is registered in ClinicalTrials.gov with Tarian Pharma as lead sponsor.

NCT NCT07457671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07457671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a Exploratory Study of TAR-0520 Gel in Prevention of Hand and Foot Syndrome
Lead sponsor
Tarian Pharma
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
June 30, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hand and foot syndrome